Mycronic (MYCR) Aktienübersicht
Mycronic AB (publ) entwickelt, fertigt und vertreibt Produktionsanlagen für die Elektronikindustrie in Schweden, dem übrigen Europa, den Vereinigten Staaten, anderen Teilen Amerikas, China, Südkorea, dem übrigen Asien und international. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 1/6 |
| Künftiges Wachstum | 4/6 |
| Vergangene Leistung | 3/6 |
| Finanzielle Gesundheit | 6/6 |
| Dividenden | 3/6 |
MYCR Community Fair Values
Create NarrativeSee what 19 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
SEK 232.58
FV
33.2% überbewertet intrinsischer Abschlag12.00%
Revenue growth p.a.
1.8k
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
Mycronic AB (publ) Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | SEK 309.80 |
| 52-Wochen-Hoch | SEK 353.20 |
| 52-Wochen-Tief | SEK 183.32 |
| Beta | 0.71 |
| 1 Monat Veränderung | -0.19% |
| 3 Monate Veränderung | 7.20% |
| 1 Jahr Veränderung | 42.44% |
| 3 Jahre Veränderung | 162.54% |
| 5 Jahre Veränderung | 142.60% |
| Veränderung seit IPO | 201.51% |
Aktuelle Nachrichten und Updates
Narrative-Update • Jul 20
MYCR: Mixed Rating Shifts And Guidance Reset Will Shape Future Upside Potential
Analysts have raised their fair value estimate for Mycronic from SEK 260.25 to SEK 311.50, citing updated assumptions around revenue growth, profit margins, and a lower expected future P/E multiple, in the context of recent mixed broker views including a SEK 385 target from SEB Equities. Analyst Commentary Analyst views on Mycronic are mixed, with some taking a more constructive stance on the stock while others have turned more cautious.
Narrative-Update • Jul 06
MYCR: Cautious Ratings And New Orders Will Shape Execution Focus
The analyst price target for Mycronic has been revised from SEK 255 to SEK 320, with analysts citing updated assumptions for revenue growth, profit margins and future P/E as they reassess the stock following a series of more cautious rating changes from SEB Equities, Nordea and DNB Carnegie. Analyst Commentary Recent commentary on Mycronic reflects a more cautious tone from several firms, yet the higher SEK 320 price target signals that some bullish analysts still see room for upside if the company delivers on the updated assumptions for revenue, margins and P/E.Recent updates
Narrative-Update • Jul 20
MYCR: Mixed Rating Shifts And Guidance Reset Will Shape Future Upside Potential
Analysts have raised their fair value estimate for Mycronic from SEK 260.25 to SEK 311.50, citing updated assumptions around revenue growth, profit margins, and a lower expected future P/E multiple, in the context of recent mixed broker views including a SEK 385 target from SEB Equities. Analyst Commentary Analyst views on Mycronic are mixed, with some taking a more constructive stance on the stock while others have turned more cautious.Narrative-Update • Jul 06
MYCR: Cautious Ratings And New Orders Will Shape Execution Focus
The analyst price target for Mycronic has been revised from SEK 255 to SEK 320, with analysts citing updated assumptions for revenue growth, profit margins and future P/E as they reassess the stock following a series of more cautious rating changes from SEB Equities, Nordea and DNB Carnegie. Analyst Commentary Recent commentary on Mycronic reflects a more cautious tone from several firms, yet the higher SEK 320 price target signals that some bullish analysts still see room for upside if the company delivers on the updated assumptions for revenue, margins and P/E.Narrative-Update • Jun 22
MYCR: Sector Downgrades And Execution Risks Will Restrain Future Upside
The latest Narrative Update on Mycronic reflects a reduced analyst price target of SEK260.25, as analysts factor in slightly lower revenue growth and profit margin assumptions, along with a modestly higher future P/E, in the context of several recent downgrades on the stock. Analyst Commentary Recent research on Mycronic points to a more cautious stance among several bearish analysts, who have downgraded the stock while reassessing revenue growth, margins, and valuation multiples.Analyseartikel • Jun 19
Mycronic (OM:MYCR) Stock Could Be 17.2% Overvalued After New SLX Order
Mycronic (OM:MYCR) stock is back in focus after the company reported a new European customer order for its SLX laser mask writer, valued at US$6 to 8 million with delivery planned in Q3 2026. See our latest analysis for Mycronic. The SLX order lands at a time when Mycronic’s short term share price momentum has been firm, with a 90 day share price return of 44.34%. The 1 year total shareholder return of 70.93% and 3 year total shareholder return of 151.03% point to strong long term...Narrative-Update • Jun 07
MYCR: Sector Downgrades And Higher Risk Perceptions Will Pressure Future Upside
Analysts have trimmed their stance on Mycronic, nudging the SEK 260.25 price target lower in line with a slightly higher discount rate and more cautious sector views following several recent rating downgrades. Analyst Commentary Recent research has taken a more cautious tone on Mycronic, with several downgrades pointing to higher required returns and more conservative sector assumptions feeding into valuation work.Narrative-Update • May 09
MYCR: Clustered Downgrades And Extended Deliveries Will Pressure Near Term Upside
The updated analyst price target for Mycronic has shifted from SEK 226.50 to SEK 260.25. Analysts cite changes in growth expectations and valuation assumptions, even as several firms have recently turned more cautious on the stock.Analyseartikel • Apr 29
Mycronic AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models
It's been a good week for Mycronic AB (publ) ( STO:MYCR ) shareholders, because the company has just released its...Narrative-Update • Apr 24
MYCR: Extended Delivery Timeline For New Orders Will Restrain Near-Term Upside
Analysts have raised their price target on Mycronic to SEK226.50 from SEK213.67, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News Order for a customized SLX mask writer from a new customer, valued between US$27 million and US$30 million, with delivery planned in 2028.Narrative-Update • Apr 09
MYCR: Asian Equipment Orders And 2026 Outlook Will Support Steady Dividend Profile
Analysts have slightly adjusted their price target on Mycronic from SEK 215 to about SEK 214. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples, while keeping their overall view broadly consistent.Narrative-Update • Mar 26
MYCR: Asian Orders And 2026 Guidance Will Underpin Stable Dividend Outlook
Analysts are maintaining their SEK 215.0 price target for Mycronic, noting only minor adjustments to inputs such as the discount rate, long-term revenue, profit margin and future P/E assumptions that do not materially change their valuation view. What's in the News Mycronic has issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (Corporate Guidance).Narrative-Update • Mar 09
MYCR: Asian Orders And 2026 Guidance Will Support Steady Dividend Outlook
Analysts have maintained their SEK 215.00 price target for Mycronic. This reflects minor adjustments to assumptions regarding the discount rate, long-term growth and P/E, which did not meaningfully change their overall view of the shares.Narrative-Update • Feb 22
MYCR: Asian Orders And 2026 Guidance Will Shape Balanced Outlook
Analysts now keep their SEK 215.0 price target for Mycronic broadly unchanged, with slight adjustments in the discount rate, revenue growth expectations, profit margin assumptions, and future P/E multiples shaping the latest narrative update. What's in the News Mycronic issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (company guidance).Analyseartikel • Feb 08
Analyst Estimates: Here's What Brokers Think Of Mycronic AB (publ) (STO:MYCR) After Its Full-Year Report
Mycronic AB (publ) ( STO:MYCR ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Narrative-Update • Feb 08
MYCR: Asian Orders And Higher Margins Will Support Bullish Outlook
Analysts have trimmed their price target on Mycronic to SEK215 from about SEK218.67, citing updated assumptions that include a slightly higher discount rate, adjusted revenue growth and profit margin expectations, and a lower future P/E multiple. What's in the News Mycronic announced an annual dividend of SEK 3.25 per share, with an ex dividend date set for May 7, 2026, a record date on May 8, 2026, and a payment date on May 13, 2026 (company announcement).Narrative-Update • Jan 24
MYCR: Asian Orders And Cautious Margins Will Support Stable Outlook
Analysts have kept their overall price target for Mycronic unchanged at SEK 218.67, with adjustments in the discount rate, profit margin and future P/E assumptions reflecting a more cautious margin outlook, offset by support from valuation multiples. What's in the News Mycronic received an order for an MMX metrology system from a new customer in Asia, valued in the range of US$2 million to US$4 million, with delivery planned for the current quarter (company announcement).Analyseartikel • Jan 23
Mycronic (STO:MYCR) Is Reinvesting To Multiply In Value
What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...Narrative-Update • Jan 08
MYCR: Asian Equipment Orders And Higher Margins Will Support Steady Outlook
Analysts have left their fair value estimate for Mycronic unchanged at SEK 218.67. The latest price target is shaped mainly by slightly revised assumptions on discount rate, revenue growth, profit margin and future P/E, which together reflect a more balanced view of the company’s earnings profile and valuation risk.Analyseartikel • Dec 31
Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)
Key Insights Mycronic's estimated fair value is kr215 based on 2 Stage Free Cash Flow to Equity Current share price of...Narrative-Update • Dec 13
MYCR: Expanding Asian Orders Will Support Steady Earnings And Balanced Prospects
Analysts have nudged their price target for Mycronic slightly higher to approximately SEK 219 per share, reflecting modestly increased discount rate and future P E assumptions, while maintaining a generally stable view on long term revenue growth and profitability. What's in the News Mycronic secured a new Asian customer for its SLX semiconductor mask writer, an energy efficient system with an order value between USD 5 million and 7 million, with revenue recognized in the current quarter (company announcement).Narrative-Update • Nov 27
MYCR: Growing Asian Orders And Margins Will Support Measured Gains Through 2025
Analysts have slightly increased their price target for Mycronic to SEK 218.67 from SEK 217.33. They cite improved revenue growth expectations and a marginally higher projected profit margin.Narrative-Update • Nov 07
MYCR: Net Profit Margins And Orders Will Support Steady Outlook Through 2025
Analysts have slightly raised their price target for Mycronic from SEK 216.67 to SEK 217.33. They cite improved profit margin forecasts and a more favorable future price-to-earnings outlook.Analyseartikel • Oct 28
Mycronic AB (publ) Just Beat Revenue Estimates By 9.4%
Mycronic AB (publ) ( STO:MYCR ) just released its quarterly report and things are looking bullish. The company beat...Narrative-Update • Oct 24
Upcoming Orders and Expansion Will Drive Global Technology Reach Forward
Analyst Price Target Update for Mycronic Analysts have raised their fair value estimate for Mycronic from SEK 207.00 to SEK 216.67. This update reflects improved revenue growth projections, even though there is a slightly higher discount rate and lower profit margin expectations.Narrative-Update • Oct 10
Acquisitions And Launches Will Expand Global Technology Reach
Narrative Update on Mycronic: Analyst Price Target Revision Analysts have revised their price target for Mycronic downward by SEK 31, from SEK 238 to SEK 207. This adjustment is based on updated forecasts for slower revenue growth and slightly softer profit margins.Analyseartikel • Sep 19
Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Mycronic fair value estimate is kr235 With kr220 share price...Narrative-Update • Aug 27
Acquisitions And Launches Will Expand Global Technology Reach
The increase in Mycronic's consensus price target to SEK238.00 reflects improved revenue growth forecasts and a modestly higher future P/E multiple. What's in the News Mycronic updated its 2025 revenue guidance, reverting to its original estimate of SEK 7.5 billion in net sales, compared to the previous range of SEK 7.0 to 7.5 billion.Analyseartikel • Aug 23
Does Mycronic (STO:MYCR) Deserve A Spot On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Analyseartikel • Aug 10
Does Mycronic (STO:MYCR) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Neues Narrative • Jun 24
Historically Cheap, but the Margin of Safety Is Still Thin
Electronics-complexity super-cycle — AI datacentres, EVs and advanced display / semiconductor nodes require ever-finer photomasks, ultra-precise die bonding and higher-reliability SMT lines, directlyAktionärsrenditen
| MYCR | SE Electronic | SE Markt | |
|---|---|---|---|
| 7D | -11.6% | 2.3% | 2.5% |
| 1Y | 42.4% | -10.4% | 11.8% |
Rendite im Vergleich zur Industrie: MYCR übertraf die Branche Swedish Electronic , die im vergangenen Jahr eine Rendite von -10.4 erzielte.
Rendite vs. Markt: MYCR übertraf den Markt Swedish, der im vergangenen Jahr eine Rendite von 11.8 erzielte.
Preisvolatilität
| MYCR volatility | |
|---|---|
| MYCR Average Weekly Movement | 6.5% |
| Electronic Industry Average Movement | 6.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 12.2% |
| 10% least volatile stocks in SE Market | 3.4% |
Stabiler Aktienkurs: MYCR hatte in den letzten 3 Monaten im Vergleich zum Swedish -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: MYCRDie wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1989 | 2,772 | Anders Lindqvist | www.mycronic.com |
Mycronic AB (publ) entwickelt, produziert und vertreibt Produktionsanlagen für die Elektronikindustrie in Schweden, dem übrigen Europa, den Vereinigten Staaten, anderen Teilen Amerikas, China, Südkorea, dem übrigen Asien und international. Das Unternehmen ist in vier Segmenten tätig: Pattern Generators, High Flex, High Volume und Global Technologies. Das Segment Pattern Generators entwickelt, fertigt und vermarktet Maskenschreiber und Messmaschinen für die Produktion von hochentwickelten Fotomasken für die Herstellung von Bildschirmen für Fernseher, Autos, Mobiltelefone, Tablets und Computer sowie für Halbleiterkomponenten.
Mycronic AB (publ)'s Grundlagenzusammenfassung
| MYCR grundlegende Statistiken | |
|---|---|
| Marktanteil | SEK 61.12b |
| Gewinn(TTM) | SEK 1.74b |
| Umsatz(TTM) | SEK 8.65b |
34.9x
Kurs-Gewinn-Verhältnis 7.0x
Kurs-Umsatz-VerhältnisIst MYCR zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| MYCR Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | SEK 8.65b |
| Kosten der Einnahmen | SEK 3.97b |
| Bruttogewinn | SEK 4.68b |
| Sonstige Ausgaben | SEK 2.95b |
| Gewinn | SEK 1.74b |
Zuletzt gemeldete Gewinne
Jun 30, 2026
Datum des nächsten Gewinnberichts
Oct 22, 2026
| Gewinn per Aktie (EPS) | 8.89 |
| Bruttomarge | 54.11% |
| Nettogewinnspanne | 20.06% |
| Schulden/Eigenkapital-Verhältnis | 3.6% |
Wie hat sich MYCR auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
1.0%
Aktuelle Dividendenrendite37%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/29 22:23 |
| Aktienkurs zum Tagesende | 2026/07/29 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Mycronic AB (publ) wird von 9 Analysten beobachtet. 4 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Nils Sjogren | ABG Sundal Collier Sponsored |
| Oliver Wong | BofA Global Research |
| Mikael Laséen | Carnegie Investment Bank AB |